Biotecnología
Biotecnología
BigHat Biosciences Partners with Janssen Biotech to Guide Antibody Discovery & Design
25/04/2024 -
Collaboration will combine the drug discovery, clinical development and data science expertise from Johnson & Johnson with BigHat’s AI/ML platform.
Moderna and OpenAI Join Forces to Transform Healthcare with AI
25/04/2024 -
Moderna is in the process of integrating generative AI responsibly and seamlessly into its operations and capitalizing on next-generation AI innovation.
CureVac Names New Chief Business Officer
25/04/2024 -
Thaminda Ramanayake offers more than 15 years of biopharma development and deal-making experience.
Hanmi, Merck Enter Clinical Collaboration & Supply Agreement
25/04/2024 -
To evaluate BH3120 in combination with Merck's KEYTRUDA in progressive or metastatic solid tumors.
PharmaLogic Opens New Radiopharmaceutical Production Facility in Cincinnati
25/04/2024 -
Production and lab space equipped to expand current production and focus additional efforts on R&D of novel compounds.
Tetra Pharm Technologies & Glysious Partner to Develop Transdermal Combination Drugs
25/04/2024 -
Aim to revolutionize transdermal release of ‘difficult-to-formulate’ compounds targeting the endocannabinoid system.
Lexeo Enters License Agreement for Friedreich Ataxia Treatment
25/04/2024 -
Aims to expedite development of investigational gene therapy candidate LX2006 for the treatment of FA cardiomyopathy.
Evotec Appoints Dr. Christian Wojczewski CEO
25/04/2024 -
Dr. Mario Polywka, who has led Evotec as Interim CEO since January 3, 2024, will retire from his position at the end of June.
BioArctic, Eisai Ink Research Agreement for BAN2802 in AD
25/04/2024 -
To evaluate potential new treatment combining BioArctic's BrainTransporter technology with an undisclosed Alzheimer drug candidate.
Sanofi’s Rilzabrutinib Meets Primary Endpoint in ITP
25/04/2024 -
Demonstrates significantly higher proportion of patients receiving rilzabrutinib achieved primary endpoint of durable platelet response versus placebo.
Ipsen and Skyhawk Therapeutics Collaborate on RNA Targeting Research
25/04/2024 -
Aim to discover and develop small molecules for the treatment of rare neurological diseases.
Sygnature Discovery Names New Chief Scientific Officer
25/04/2024 -
Industry veteran Dr. David Witty joins from Eliem Therapeutics, where he served as Vice President of Chemistry and Intellectual Property.
Takeda and Astellas Agree to Establish Joint Venture Company
25/04/2024 -
New joint venture aims to cover the entire drug discovery process, spanning early drug discovery research through the inception of drug discovery startups.
Particle Dynamics Names New Chief Financial Officer
25/04/2024 -
Industry veteran Mike Kanan joins with more than 30 years of finance experience spanning private equity-owned and public companies.
SystImmune Names New CEO
25/04/2024 -
Taps former Bristol Myers Squibb exec with 20 years’ experience in the biopharmaceutical industry.
SnapSlide Introduces No-Torque, Child-Resistant Caps
25/04/2024 -
Feature a patented, sliding, two-step opening procedure that allows for single-handed opening and closing.
Flare Therapeutics Names New CEO
25/04/2024 -
Dr. Douglas Manion brings over two decades of experience in pharmaceutical research and development.
Tharimmune Announces Option for Novel HER2/HER3 Cancer Therapies
25/04/2024 -
Obtains rights from Washington University to develop and incorporate human HER2 directed antibodies.
Tower Cold Chain Introduces KTEvolution 12 Containers
25/04/2024 -
Designed for transport of thermally sensitive products requiring internal temperatures ranging from
Vertex Obtains Exclusive License to TreeFrog’s C-Stem Technology
25/04/2024 -
Aims to optimize production of its cell therapies for type 1 diabetes.
BMS & Cellares Announce Worldwide Capacity Reservation & Supply Agreement
25/04/2024 -
Enables Bristol Myers Squibb to expand its manufacturing capacity, meeting the growing demand for its range of cell therapies through Cellares’ platform.
